PGP and cancer: SSa can increase the chemosensitivity of P-gp-overexpressing HepG2/adriamycin (ADR) and MCF-7/ADR MDR cancer cells to doxorubicin, vincristine, and paclitaxel by promoting apoptosis, increasing the retention of drugs, and reducing P-gp expression [32].